Canaccord Genuity Upgrades Transition Therapeutics (TTHI) to Spec Buy
Tweet Send to a Friend
Canaccord Genuity upgraded Transition Therapeutics (NASDAQ: TTHI) from Hold to Speculative Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
